Strategic Global Advisors, LLC Novartis Ag Transaction History

Strategic Global Advisors, LLC

  • $633 Million
  • Q3 2025

A detailed history of Strategic Global Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 13,182 shares of NVS stock, worth $1.73 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
13,182
Previous 14,247 7.48%
Holding current value
$1.73 Million
Previous $1.72 Million 1.97%
% of portfolio
0.27%
Previous 0.29%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$113.5 - $129.73 $120,877 - $138,162
-1,065 Reduced 7.48%
13,182 $1.69 Million
Q2 2025

Aug 14, 2025
BUY
$101.96 - $121.01 $176,594 - $209,589
1,732 Added 13.84%
14,247 $1.72 Million
Q1 2025

May 15, 2025
SELL
$97.14 - $115.57 $28,753 - $34,208
-296 Reduced 2.31%
12,515 $1.4 Million
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $89,037 - $107,805
920 Added 7.74%
12,811 $1.25 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $683,477 - $778,531
6,440 Added 118.14%
11,891 $1.37 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $489,325 - $567,557
-5,286 Reduced 49.23%
5,451 $580,000
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $9,812 - $11,172
-103 Reduced 0.95%
10,737 $1.04 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $23,067 - $25,385
-250 Reduced 2.25%
10,840 $1.09 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $71,615 - $79,478
-756 Reduced 6.38%
11,090 $1.13 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $21,649 - $24,548
-234 Reduced 1.94%
11,846 $1.2 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $613,269 - $711,203
7,663 Added 173.49%
12,080 $1.11 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $1,662 - $2,035
-22 Reduced 0.5%
4,417 $400,000
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $15,145 - $17,713
203 Added 4.79%
4,439 $337,000
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $5,233 - $6,093
-65 Reduced 1.51%
4,236 $358,000
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $4,966 - $5,618
62 Added 1.46%
4,301 $377,000
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $1.35 Million - $1.49 Million
-16,912 Reduced 79.96%
4,239 $1.67 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $4,825 - $5,613
-59 Reduced 0.28%
21,151 $1.73 Million
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $2.47 Million - $2.72 Million
-28,939 Reduced 57.71%
21,210 $1.94 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $10,437 - $12,308
125 Added 0.25%
50,149 $4.29 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $134,826 - $163,080
-1,727 Reduced 3.34%
50,024 $4.72 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $467,540 - $517,972
5,692 Added 12.36%
51,751 $4.5 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $895,247 - $1.01 Million
11,062 Added 31.61%
46,059 $4.02 Million
Q1 2020

May 14, 2020
BUY
$70.67 - $99.01 $536,243 - $751,287
7,588 Added 27.68%
34,997 $2.89 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $431,787 - $488,199
5,119 Added 22.97%
27,409 $2.6 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $9,238 - $10,180
108 Added 0.49%
22,290 $1.94 Million
Q2 2019

Aug 13, 2019
BUY
$75.4 - $92.8 $11,310 - $13,920
150 Added 0.68%
22,182 $2.03 Million
Q1 2019

May 13, 2019
BUY
$75.32 - $86.15 $1.32 Million - $1.51 Million
17,474 Added 383.37%
22,032 $2.12 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $43,385 - $48,309
-589 Reduced 11.44%
4,558 $391,000
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $10,710 - $12,388
160 Added 3.21%
5,147 $443,000
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $8,306 - $9,929
118 Added 2.42%
4,987 $403,000
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $352,174 - $378,029
4,869
4,869 $409,000

Others Institutions Holding NVS

# of Institutions
1,612
Shares Held
136M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Strategic Global Advisors, LLC Portfolio

Follow Strategic Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email